EMC Capital Management’s Exagen XGN Stock Holding History

EMC Capital Management’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-32,447	Closed	-$377K	–	129
2021 Q3	$377K	Hold	32,447	–	–	0.21%	80
2021 Q2	$486K	Buy	+32,447	New	+$497K	0.28%	81

Other funds holding XGN

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

EMC Capital Management's XGN Position: Q4 2021 in Review

EMC Capital Management sold out of Exagen (XGN) in Q4 2021, closing a stake of 32,447 shares — an estimated $377K sold.

EMC Capital Management first reported a position in XGN in Q2 2021 and held it in 2 quarters. The position peaked at $486K in Q2 2021. 53 funds tracked by Wall St. Rank hold XGN as of Q4 2021.

EMC Capital Management reported no remaining Exagen position as of Q4 2021 after selling out during the quarter.
EMC Capital Management sold 32,447 Exagen shares in Q4 2021, an estimated $377K.
EMC Capital Management first reported a position in Exagen in Q2 2021 and held it in 2 quarters.
EMC Capital Management's Exagen position peaked at $486K in Q2 2021.
53 funds tracked by Wall St. Rank held Exagen as of Q4 2021.

Based on EMC Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.